A research study of a new medicine NNC0363-1063 in healthy participants and participants with type 1 diabetes
NN1644-7794
Phase 1 other active
Quick answer
A research study of a new medicine NNC0363-1063 in healthy participants and participants with type 1 diabetes for Type 1 diabetes mellitus is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Type 1 diabetes mellitus
- Phase
- Phase 1
- Modality
- other
- Status
- active